Bisphosphonates for Patients Diagnosed With Multiple Myeloma


    loading  Checking for direct PDF access through Ovid

Abstract

Clinical QuestionAmong patients with multiple myeloma, is bisphosphonate therapy associated with lower rates of mortality, vertebral fractures, nonvertebral fractures, and skeletal-related events compared with placebo or no treatment?Bottom LineAmong patients with myeloma, bisphosphonates were associated with lower rates of pathological fractures and skeletal-related events compared with placebo or no treatment. Direct meta-analysis showed no association between bisphosphonates and mortality. In network meta-analysis, zoledronate was associated with lower risk of mortality compared with placebo or no treatment.

    loading  Loading Related Articles